Skip to content

Content Header

R44640 – Patents and Prescription Drug Importation – 10/4/2016

R44640 – Patents and Prescription Drug Importation – 10/4/2016 published on

Author: John R. Thomas, Visiting Scholar
Pages: 16

This report reviews the availability of march-in rights under the Bayh-Dole Act. It begins by providing a brief overview of the patent system and innovation policy. The report then introduces the Bayh-Dole Act. The specific details of the march-in authority provided to federal agencies are reviewed next. The report then considers past efforts to obtain march-in authorization from NIH. The report closes with an identification of potential issues for congressional consideration.

Primary Sidebar